FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3093840081> ?p ?o ?g. }

• W3093840081 endingPage "1" @default.
• W3093840081 startingPage "1" @default.
• W3093840081 abstract "Acute myeloid leukemia with normal karyotype (NK‑AML) is a group of diseases with high heterogeneity and immunological processes are significantly associated with its initiation and development. The implication of the immunogenomic landscape in the prognosis of patients with NK‑AML has remained largely elusive. In the present study, the expression profiles of immune‑related genes (IRGs) were examined and their association with overall survival (OS) was determined in 60 patients with NK‑AML from The Cancer Genome Atlas dataset and 104 patients from the Gene Expression Omnibus (GEO) dataset no. GSE71014. Univariate Cox regression analysis was used to identify 42 and 203 IRGs in the two respective cohorts, which were significantly associated with OS in NK‑AML. A risk model was constructed based on the regression coefficient and expression values of nine survival‑associated IRGs shared between the two datasets [zinc finger CCCH‑type containing, antiviral 1 like; transferrin receptor; suppressor of cytokine signaling 1; ELAV like RNA binding protein 1; roundabout guidance receptor 3; unc‑93 homolog B1, Toll‑like receptor signaling regulator; protein tyrosine phosphatase non‑receptor type 6; interleukin 2 receptor subunit alpha (IL2RA) and IL3RA]. Using this risk model, patients with NK‑AML may be divided into high‑ and low‑risk groups in prognostic predictions. The area under the receiver operating characteristic curve for predicting OS was 0.793. The prognostic role of this risk model was successfully verified in another independent cohort (GEO dataset no. GSE71014). The prognostic risk score was positively associated with age and fms related receptor tyrosine kinase 3 mutation and correlated with infiltration by T regulatory cells. In conclusion, the results of the present study provided an IRG score model for prognostic stratification of adult patients with NK‑AML, as well as further insight into the implication of IRGs in NK‑AML that may lead to the development of novel immunotherapy approaches for this disease." @default.
• W3093840081 created "2020-10-29" @default.
• W3093840081 creator A5010776860 @default.
• W3093840081 creator A5014790362 @default.
• W3093840081 creator A5017384752 @default.
• W3093840081 creator A5042419848 @default.
• W3093840081 creator A5045703368 @default.
• W3093840081 creator A5056457925 @default.
• W3093840081 creator A5064222660 @default.
• W3093840081 creator A5070528958 @default.
• W3093840081 creator A5078362508 @default.
• W3093840081 date "2020-10-23" @default.
• W3093840081 modified "2023-10-10" @default.
• W3093840081 title "Immune prognostic risk score model in acute myeloid leukemia with normal karyotype" @default.
• W3093840081 cites W1255676896 @default.
• W3093840081 cites W1492609361 @default.
• W3093840081 cites W1503306485 @default.
• W3093840081 cites W1534965621 @default.
• W3093840081 cites W1575225113 @default.
• W3093840081 cites W1827289845 @default.
• W3093840081 cites W1911726069 @default.
• W3093840081 cites W1926720864 @default.
• W3093840081 cites W1973846920 @default.
• W3093840081 cites W1982960076 @default.
• W3093840081 cites W1985987855 @default.
• W3093840081 cites W1990595263 @default.
• W3093840081 cites W1991509879 @default.
• W3093840081 cites W2025738474 @default.
• W3093840081 cites W2045587009 @default.
• W3093840081 cites W2069317205 @default.
• W3093840081 cites W2084878791 @default.
• W3093840081 cites W2095012072 @default.
• W3093840081 cites W2098218248 @default.
• W3093840081 cites W2102107035 @default.
• W3093840081 cites W2109280977 @default.
• W3093840081 cites W2139276258 @default.
• W3093840081 cites W2142548185 @default.
• W3093840081 cites W2145443669 @default.
• W3093840081 cites W2147860795 @default.
• W3093840081 cites W2161717556 @default.
• W3093840081 cites W2287607757 @default.
• W3093840081 cites W2384094940 @default.
• W3093840081 cites W2476042999 @default.
• W3093840081 cites W2572650036 @default.
• W3093840081 cites W2577524058 @default.
• W3093840081 cites W2728020099 @default.
• W3093840081 cites W2741315569 @default.
• W3093840081 cites W2742727395 @default.
• W3093840081 cites W2777359937 @default.
• W3093840081 cites W2897450351 @default.
• W3093840081 cites W2903041954 @default.
• W3093840081 cites W2916458303 @default.
• W3093840081 cites W2922061899 @default.
• W3093840081 cites W2947030229 @default.
• W3093840081 cites W2982084340 @default.
• W3093840081 doi "https://doi.org/10.3892/ol.2020.12243" @default.
• W3093840081 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7608030" @default.
• W3093840081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33154778" @default.
• W3093840081 hasPublicationYear "2020" @default.
• W3093840081 type Work @default.
• W3093840081 sameAs 3093840081 @default.
• W3093840081 citedByCount "8" @default.
• W3093840081 countsByYear W30938400812021 @default.
• W3093840081 countsByYear W30938400812022 @default.
• W3093840081 countsByYear W30938400812023 @default.
• W3093840081 crossrefType "journal-article" @default.
• W3093840081 hasAuthorship W3093840081A5010776860 @default.
• W3093840081 hasAuthorship W3093840081A5014790362 @default.
• W3093840081 hasAuthorship W3093840081A5017384752 @default.
• W3093840081 hasAuthorship W3093840081A5042419848 @default.
• W3093840081 hasAuthorship W3093840081A5045703368 @default.
• W3093840081 hasAuthorship W3093840081A5056457925 @default.
• W3093840081 hasAuthorship W3093840081A5064222660 @default.
• W3093840081 hasAuthorship W3093840081A5070528958 @default.
• W3093840081 hasAuthorship W3093840081A5078362508 @default.
• W3093840081 hasBestOaLocation W30938400811 @default.
• W3093840081 hasConcept C121608353 @default.
• W3093840081 hasConcept C126322002 @default.
• W3093840081 hasConcept C143998085 @default.
• W3093840081 hasConcept C203014093 @default.
• W3093840081 hasConcept C2778729363 @default.
• W3093840081 hasConcept C29537977 @default.
• W3093840081 hasConcept C502942594 @default.
• W3093840081 hasConcept C50382708 @default.
• W3093840081 hasConcept C67082663 @default.
• W3093840081 hasConcept C71924100 @default.
• W3093840081 hasConcept C86803240 @default.
• W3093840081 hasConceptScore W3093840081C121608353 @default.
• W3093840081 hasConceptScore W3093840081C126322002 @default.
• W3093840081 hasConceptScore W3093840081C143998085 @default.
• W3093840081 hasConceptScore W3093840081C203014093 @default.
• W3093840081 hasConceptScore W3093840081C2778729363 @default.
• W3093840081 hasConceptScore W3093840081C29537977 @default.
• W3093840081 hasConceptScore W3093840081C502942594 @default.
• W3093840081 hasConceptScore W3093840081C50382708 @default.
• W3093840081 hasConceptScore W3093840081C67082663 @default.
• W3093840081 hasConceptScore W3093840081C71924100 @default.
• W3093840081 hasConceptScore W3093840081C86803240 @default.

• next